{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:56:51Z","timestamp":1755601011538,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["Junior Clinical Investigator Award"],"award-info":[{"award-number":["Junior Clinical Investigator Award"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","award":["Stora Etableringsanslaget"],"award-info":[{"award-number":["Stora Etableringsanslaget"]}],"id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Follicular thyroid carcinoma (FTC) is a neoplasm that presents with a micro-follicular growth pattern and a neutrally stained cytoplasm. Seldom, FTCs display unusual morphological characteristics \u2013 but given the rarity of these histological subtypes, little is known regarding the underlying genetics and the coupling to patient outcome.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>We present two extremely rare cases of minimally invasive FTC with signet ring cell morphology (SRC-FTC) and describe the cytological, microscopic, immunohistochemical and molecular features for both tumors. Both were male patients, age 71 and 51 respectively. The preoperative cytology for both cases could not pinpoint a clear-cut signet ring cell morphology, but a tendency towards nuclear marginalization was seen. The tumors were 38\u2009mm and 22\u2009mm respectively and displayed evident signet ring cell features in subsets of tumor cells as well as degenerative stromal changes. The tumor cells were positive for TTF1, PAX8 and thyroglobulin, and the proliferation indexes were 4% and 1,9% respectively. Both tumors displayed capsular invasion, but not lymphovascular invasion. The tumors were sequenced for mutations in the <jats:italic>TERT<\/jats:italic> promoter and 22 additional cancer-related genes, interestingly; one patient was shown to carry a deleterious intronic variant in <jats:italic>PTEN<\/jats:italic>, a tumor suppressor gene coupled to thyroid tumorigenesis and Cowden syndrome. Both patients are alive and well awaiting postoperative radioiodine treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The SRC-FTCs described herein were small, <jats:italic>TERT<\/jats:italic> promoter wildtype tumors exhibiting low proliferation, thereby suggesting that these exceedingly rare lesions probably carry a favorable prognosis \u2013 although the scarce availability regarding descriptions of this tumor entity nevertheless might justify careful clinical monitoring and mandate investigations in larger case series.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13000-019-0904-3","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T17:03:59Z","timestamp":1573146239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Signet ring cell variant of follicular thyroid carcinoma: Report of two cases with focus on morphological, expressional and genetic characteristics"],"prefix":"10.1186","volume":"14","author":[{"given":"Martin","family":"Hysek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenbugul","family":"Jatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Stenman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Darai-Ramqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Zedenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"H\u00f6\u00f6g","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5945-9081","authenticated-orcid":false,"given":"C. Christofer","family":"Juhlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"unstructured":"Weltgesundheitsorganisation, Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J, International Agency for Research on Cancer, editors. WHO classification of tumours of endocrine organs. 4th edition. Lyon: International Agency for Research on Cancer; 2017. 355 p. (World Health Organization classification of tumours).","key":"904_CR1"},{"issue":"10","key":"904_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/00000478-198510000-00002","volume":"9","author":"ML Carcangiu","year":"1985","unstructured":"Carcangiu ML, Sibley RK, Rosai J. Clear cell change in primary thyroid tumors. A study of 38 cases. Am J Surg Pathol. 1985 Oct;9(10):705\u201322.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"904_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5114\/reum.2017.69774","volume":"55","author":"A Handra-Luca","year":"2017","unstructured":"Handra-Luca A. Signet-ring cell adenoma of the thyroid and rheumatoid arthritis: incidental association or methotrexate-related change? Reumatologia. 2017;55(4):155\u20136.","journal-title":"Reumatologia."},{"issue":"9","key":"904_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/00000478-198509000-00001","volume":"9","author":"S Schr\u00f6der","year":"1985","unstructured":"Schr\u00f6der S, B\u00f6cker W. Signet-ring-cell thyroid tumors. Follicle cell tumors with arrest of folliculogenesis. Am J Surg Pathol. 1985 Sep;9(9):619\u201329.","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"904_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12022-013-9271-x","volume":"24","author":"AE Romero-Rojas","year":"2013","unstructured":"Romero-Rojas AE, Diaz-Perez JA, Mastrodimos M, Chinchilla SI. Follicular thyroid carcinoma with signet ring cell morphology: fine-needle aspiration cytology, histopathology, and immunohistochemistry. Endocr Pathol. 2013;24(4):239\u201345.","journal-title":"Endocr Pathol"},{"issue":"3","key":"904_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/ajcp\/aqx074","volume":"148","author":"NA Farhat","year":"2017","unstructured":"Farhat NA, Onenerk AM, Krane JF, Dias-Santagata D, Sadow PM, Faquin WC. Primary benign and malignant thyroid neoplasms with signet ring cells: Cytologic, histologic, and molecular features. Am J Clin Pathol. 2017;148(3):251\u20138.","journal-title":"Am J Clin Pathol"},{"key":"904_CR7","first-page":"106689691880949","volume":"29","author":"CC Juhlin","year":"2018","unstructured":"Juhlin CC, Br\u00e4nstr\u00f6m R, Shabo I, H\u00f6\u00f6g A. Clear cell variant of a follicular thyroid tumor with uncertain malignant potential: a case report. Int J Surg Pathol. 2018 Oct;29:1066896918809490.","journal-title":"Int J Surg Pathol"},{"key":"904_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2407-12-55","volume":"12","author":"MG Chiofalo","year":"2012","unstructured":"Chiofalo MG, Losito NS, Fulciniti F, Setola SV, Tommaselli A, Marone U, et al. Axillary node metastasis from differentiated thyroid carcinoma with H\u00fcrthle and signet ring cell differentiation. A case of disseminated thyroid cancer with peculiar histologic findings. BMC Cancer. 2012;12:55.","journal-title":"BMC Cancer"},{"issue":"40","key":"904_CR9","doi-asserted-by":"publisher","first-page":"11428","DOI":"10.3748\/wjg.v21.i40.11428","volume":"21","author":"S Pernot","year":"2015","unstructured":"Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: impact on prognosis and specific therapeutic challenge. World J Gastroenterol. 2015;21(40):11428\u201338.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"904_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.bbrc.2007.01.133","volume":"355","author":"A Yokoyama","year":"2007","unstructured":"Yokoyama A, Shi B-H, Kawai T, Konishi H, Andoh R, Tachikawa H, et al. Muc4 is required for activation of ErbB2 in signet ring carcinoma cell lines. Biochem Biophys Res Commun. 2007;355(1):200\u20133.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"904_CR11","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.bbrc.2014.07.025","volume":"450","author":"Y Fukui","year":"2014","unstructured":"Fukui Y. Mechanisms behind signet ring cell carcinoma formation. Biochem Biophys Res Commun. 2014;450(4):1231\u20133.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"904_CR12","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1002\/humu.23288","volume":"38","author":"HJ Chen","year":"2017","unstructured":"Chen HJ, Romigh T, Sesock K, Eng C. Characterization of cryptic splicing in germline PTEN intronic variants in Cowden syndrome. Hum Mutat. 2017;38(10):1372\u20137.","journal-title":"Hum Mutat"},{"issue":"17","key":"904_CR13","doi-asserted-by":"publisher","first-page":"15628","DOI":"10.18632\/oncotarget.3858","volume":"6","author":"V Leone","year":"2015","unstructured":"Leone V, Langella C, Esposito F, Arra C, Palma G, Rea D, et al. Ccdc6 knock-in mice develop thyroid hyperplasia associated to an enhanced CREB1 activity. Oncotarget. 2015 20;6(17):15628\u201338.","journal-title":"Oncotarget"},{"doi-asserted-by":"crossref","unstructured":"Chen X, Li M, Zhou H, Zhang L. miR-132 targets FOXA1 and exerts tumor-suppressing functions in thyroid cancer. Oncol Res. 2018;","key":"904_CR14","DOI":"10.3727\/096504018X15201058168730"},{"doi-asserted-by":"crossref","unstructured":"Fang M, Huang W, Wu X, Gao Y, Ou J, Zhang X, et al. MiR-141-3p suppresses tumor growth and metastasis in papillary thyroid Cancer via targeting yin Yang 1. Anat Rec (Hoboken). 2018.","key":"904_CR15","DOI":"10.1002\/ar.23940"},{"issue":"6","key":"904_CR16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00428-013-1419-z","volume":"462","author":"G Gauchotte","year":"2013","unstructured":"Gauchotte G, Lacomme S, Brochin L, Tournier B, Cahn V, Monhoven N, et al. Retinoid acid receptor expression is helpful to distinguish between adenoma and well-differentiated carcinoma in the thyroid. Virchows Arch. 2013 Jun;462(6):619\u201332.","journal-title":"Virchows Arch"},{"issue":"5","key":"904_CR17","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00428-018-2386-1","volume":"473","author":"M Hysek","year":"2018","unstructured":"Hysek M, Paulsson JO, Wang N, Jatta K, Lindh C, Fuentes-Martinez N, et al. TERT promoter mutational screening as a tool to predict malignant behaviour in follicular thyroid tumours-three examples from the clinical routine. Virchows Arch. 2018 Nov;473(5):639\u201343.","journal-title":"Virchows Arch"},{"issue":"7","key":"904_CR18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1530\/ERC-18-0050","volume":"25","author":"JO Paulsson","year":"2018","unstructured":"Paulsson JO, Mu N, Shabo I, Wang N, Zedenius J, Larsson C, et al. TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours. Endocr Relat Cancer. 2018;25(7):723\u201333.","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"904_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004962","volume":"12","author":"J Bendl","year":"2016","unstructured":"Bendl J, Musil M, \u0160toura\u010d J, Zendulka J, Damborsk\u00fd J, Brezovsk\u00fd J. PredictSNP2: a unified platform for accurately evaluating SNP effects by exploiting the different characteristics of variants in distinct genomic regions. PLoS Comput Biol. 2016;12(5):e1004962.","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"904_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014 Apr;11(4):361\u20132.","journal-title":"Nat Methods"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-019-0904-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13000-019-0904-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-019-0904-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T00:17:01Z","timestamp":1604621821000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-019-0904-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["904"],"URL":"https:\/\/doi.org\/10.1186\/s13000-019-0904-3","relation":{},"ISSN":["1746-1596"],"issn-type":[{"type":"electronic","value":"1746-1596"}],"subject":[],"published":{"date-parts":[[2019,11,7]]},"assertion":[{"value":"2 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval has been acquired by the local ethical committee, and informed consent has been obtained from the individual patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Both patients have given consent for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}